AAO research
The AAO found a dental-scanning developer’s commercialization, recognition, and independent coverage established final merits and sustained the appeal.
Decision snapshot
Decision detail | Source-backed value |
|---|---|
Decision ID | DEC092024_02B2203 |
Disposition stated in the source | Appeal sustained; EB-1A eligibility established. |
Source location |
Three categories had already been accepted
The software developer specialized in 3D digital scanning and served as a chief technical officer for a dental-scanning manufacturer and its U.S. subsidiary. The Director had accepted awards, published material, and leading or critical role but denied final merits. The AAO reviewed the whole record rather than deciding the additional contributions and remuneration categories.
Source: DEC092024_02B2203 page 2.
Commercialization did not require use by competitors
The AAO considered patents, development leadership, widely used dental products, substantial global market share, and independent recognition. It explained that exclusive patented technology need not be adopted by rival manufacturers to demonstrate commercialization. Product sales could show influence in this record. This discussion did not separately grant the contributions criterion.
Source: DEC092024_02B2203 page 3.
Independent coverage linked the person to successful products
Although some media were promotional, other trade reporting named the developer and explained his responsibility for successful products. The AAO found this coverage went beyond company press releases and sponsored articles. The combined evidence established eligibility, and the appeal was sustained.
Source: DEC092024_02B2203 page 4.
Current framework and related reading
The decisions above are non-precedent assessments of particular records. Historical reasoning is identified as historical; consult current guidance for the present framework.